Characterization of RAGE, HMGB1, and S100β in inflammation-induced preterm birth and fetal tissue injury

American Journal of Pathology

Volumn 175, Issue 3, 2009, Pages 958-975

  Buhimschi, Catalin S ^a   Baumbusch, Margaret A ^a   Dulay, Antonette T ^a   Oliver, Emily A ^a,b   Lee, Sarah ^a   Zhao, Guomao ^a   Bhandari, Vineet ^a   Ehrenkranz, Richard A ^a   Weiner, Carl P ^c   Madri, Joseph A ^a   Buhimschi, Irina A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6; PROTEIN S100B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; CELL DAMAGE; CONTROLLED STUDY; FEMALE; FETAL TISSUE INJURY; FETUS; FETUS CIRCULATION; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MOUSE; NEWBORN; NONHUMAN; ORGAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY;

EID: 70349260234     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090156     Document Type: Article

References (86)

1. Behrman RE, Butler AS, editors. Institute of Medicine Committee on Understanding Premature Birth and Assuring Health Outcomes Board on Health Sciences outcomes: Preterm Birth. Causes, Consequences, and Prevention. Institute of Medicine of the National Academies. Washington D.C., The National Academies Press, 2007
2. Allen MC: Neurodevelopmental outcomes of preterm infants: Curr Opin Neurol 2008, 21:123-128
3. Bhandari A, Panitch HB: Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006, 30:219-226
4. Robertson CM, Watt MJ, Yasui Y: Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 2007, 297:2733-2740
5. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD: National Institute of Child Health and Human Development Neonatal Research Network. Intensive care for extreme prematurity-moving beyond gestational age. N Engl J Med 2008, 358:1672-1681
6. Gaudet LM, Smith GN: Cerebral palsy and chorioamnionitis: the inflammatory cytokine link. Obstet Gynecol Surv 2001, 56:433-436 (Pubitemid 32625126)
7. Buhimschi CS, Dulay AT, Abdel-Razeq S, Zhao G, Lee S, Hodgson EJ, Bhandari V, Buhimschi IA: Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG 2009, 116:257-267
8. Dammann O, Leviton A, Gappa M, Dammann CE: Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. BJOG. 2005, 112 Suppl 1:4-9
9. Ferriero DM: Neonatal brain injury. N Engl J Med 2004, 351:1985-1995
10. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, Laptook A, Walsh M, Oh W, Hale E: Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005, 24:635-639 (Pubitemid 40993620)
11. Eschenbach DA: Amniotic fluid infection and cerebral palsy. Focus on the fetus. JAMA 1997, 278:247-248
12. Haynes RL, Baud O, Li J, Kinney HC, Volpe JJ, Folkerth DR: Oxidative and nitrative injury in periventricular leukomalacia. Brain Pathol 2005, 15:225-233
13. Medzhitov R: Origin and physiological roles of inflammation. Nature 2008, 454:428-435
14. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tör M, Billiar T: The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007, 220:60-81 (Pubitemid 350045579)
15. Bianchi ME: DAMPs PAM: Ps and alarmins: all we need to know about danger. J Leukoc Biol 2007, 8:1-5
16. Yang H, Tracey KJ: High mobility group box 1 (HMGB1). Crit Care Med 2005, 33:S472-S474 (Pubitemid 41785992)
17. Rauvala H, Rouhiainen A: RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease. Curr Mol Med 2007, 7:725-734
18. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992, 267:14998-15004
19. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A: Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993, 143:1699-1712 (Pubitemid 24058273)
20. Zen K, Chen CX, Chen YT, Wilton R, Liu Y: Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium. J Immunol 2007, 178:2483-2490 (Pubitemid 46233449)
21. Fehrenbach H, Kasper M, Tschernig T, Shearman MS, Schuh D, Müller M: Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol (Noisy-le-grand) 1998, 44:1147-1157
22. Butscheid M, Hauptvogel P, Fritz P, Klotz U, Alscher DM: Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease. J Clin Pathol 2007, 60:415-418 (Pubitemid 46596562)
23. Tang D, Kang R, Xiao W, Zhang H, Lotze MT, Wang H, Xiao X: Quercetin prevents lipopolysaccharide-induced HMGB1 release and proinflammatory function. Am J Respir Cell Mol Biol 2009. doi:10.1165/rcmb.2008.0119OC
24. Yang H, Ochani M, Li J, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004, 101:296-301 (Pubitemid 38084244)
25. Zhang H, Tasaka S, Shiraishi Y, Fukunaga K, Yamada W, Seki H, Ogawa Y, Miyamoto K, Nakano Y, Hasegawa N, Miyasho T, Maruyama I, Ishizaka A: Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008, 178:356-362
26. Lutterloh EC, Opal SM, Pittman DD, Keith JC Jr., Tan XY, Clancy BM, Palmer H, Milarski K, Sun Y, Palardy JE, Parejo NA, Kessimian N: Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection. Crit Care 2007, 11:R122
27. Ekong U, Zeng S, Dun H, Feirt N, Guo J, Ippagunta N, Guarrera JV, Lu Y, Weinberg A, Qu W, Ramasamy R, Schmidt AM, Emond JC: Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. J Gastroenterol Hepatol 2006, 21:682-688
28. Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, Dun H, Lu Y, Qu W, Schmidt AM, Emond JC: Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 2004, 39:422-432 (Pubitemid 38222183)
29. Stern D, Yan SD, Yan SF, Schmidt AM: Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 2002, 54:1615-1625 (Pubitemid 35346835)
30. Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, Tracey KJ, Bendszus M, Rossetti G, Nawroth PP, Bierhaus A, Schwaninger M: The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008, 28:12023-12031
31. Buhimschi IA, Zhao G, Pettker CM, Bahtiyar MO, Magloire LK, Thung S, Fairchild T, Buhimschi CS: The receptor for advanced glycation end products (RAGE) system in women with intra-amniotic infection and inflammation. Am J Obstet Gynecol 2007;196:181.e1-181.e13 (Pubitemid 46239979)
32. Buhimschi IA, Christner R, Buhimschi CS: Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 2005, 112:173-181 (Pubitemid 40188245)
33. Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, Büchler MW, Weigand MA: sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008, 147:79-83 (Pubitemid 351626081)
34. Azpurua H, Dulay AT, Buhimschi IA, Bahtiyar MO, Funai E, Abdel-Razeq SS, Luo G, Bhandari V, Copel JA, Buhimschi CS: Fetal artery impedance as assessed by Doppler ultrasound in pregnancies complicated by intra-amniotic inflammation and preterm birth. Am J Obstet Gynecol 2009, 200:203.e1-203.e11
35. Buhimschi IA, Buhimschi CS, Weiner CP: Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol 2003, 188:203-208
36. Hadlock FP, Deter RL, Harrist RB, Park SK: Computer assisted analysis of fetal age in the third trimester using multiple fetal growth parameters. J Clin Ultrasound 1983, 11:313-316
37. ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2007;109:1007-1019
38. Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, Sfakianaki AK, Pettker CM, Magloire L, Funai E, Norwitz ER, Paidas M, Copel JA, Weiner CP, Lockwood CJ, Buhimschi IA: Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 2007, 4:e18 (Pubitemid 46191824)
39. Naeye RL: Disorders of the placenta and decidua. In: Naeye RL (ed) Disorder of the Placenta, Fetus and Neonate: Diagnosis and Clinical Significance. St. Louis, Mosby, 1992, pp. 118-247
40. Salafia CM, Weigl C, Silberman L: The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol 1989, 73:383-389 (Pubitemid 19063617)
41. Ghidini A, Salafia CM, Kirn V, Doria V, Spong CY: Biophysical profile in predicting acute ascending infection in preterm rupture of membranes before 32 weeks. Obstet Gynecol 2000, 96:201-206 (Pubitemid 30447339)
42. Bhandari V, Wang C, Rinder C, Rinder H: Hematologic profile of sepsis in neonates: neutrophil CD64 as a diagnostic marker. Pediatrics 2008, 121:129-134
43. Rodwell RL, Taylor KM, Tudehope DI, Gray PH: Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns. Pediatr Infect Dis J 1993, 12:372-376
44. Smulian JC, Bhandari V, Campbell WA, Rodis JF, Vintzileos AM: Value of umbilical artery and vein levels of interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis. J Matern Fetal Med 1997, 6:254-259 (Pubitemid 27469192)
45. Damoiseaux JG, Döpp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD: Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994, 83:140-147 (Pubitemid 24285411)
46. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D: The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 1995, 92:9580-9584
47. Kina T, Ikuta K, Takayama E, Wada K, Majumdar AS, Weissman IL, Katsura Y: The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol 2000, 109:280-287 (Pubitemid 30350706)
48. McCarthy KS, Miller LS, Cox EB, Konrath J, McCarthy KS Sr: Estrogen receptor analysis: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985, 109:716-721
49. Zammit C, Barnard R, Gomm J, Coope R, Shousha S, Coombes C, Johnston C: Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer. J Pathol 2001, 194:27-34 (Pubitemid 32390445)
50. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D: The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995, 270:25752-25761
51. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ: Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998, 18:6241-6253 (Pubitemid 28373231)
52. Young HM, Bergner AJ, Müller T: Acquisition of neuronal and glial markers by neural crest-derived cells in the mouse intestine. J Comp Neurol 2003, 456:1-11
53. Chou DK, Zhang J, Smith FI, McCaffery P, Jungalwala FB: Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration. J Neurochem 2004, 90:1389-1401 (Pubitemid 39223642)
54. Leviton A: Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev Med Child Neurol 1993, 35:553-558
55. Mittendorf R, Montag AG, MacMillan W, Janeczek S, Pryde PG, Besinger RE, Gianopoulos JG, Roizen N: Components of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic outcomes in children. Am J Obstet Gynecol 2003, 188:1438-1446 (Pubitemid 36741271)
56. Dammann O, Leviton A: Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 2000, 12:99-104 (Pubitemid 30165567)
57. Kantar M, Kültürsay N, Kütükçüler N, Akisü M, Cetingül N, Caglayan S: Plasma concentrations of granulocyte-macrophage colony-stimulating factor and interleukin-6 in septic and healthy preterms. Eur J Pediatr 2000, 159:156-167 (Pubitemid 30139939)
58. Romagnoli C, Frezza S, Cingolani A, De Luca A, Puopolo M, De Carolis MP, Vento G, Antinori A, Tortorolo G: Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 2001, 160:345-350 (Pubitemid 32449145)
59. Andrews WW, Cliver SP, Biasini F, Peralta-Carcelen AM, Rector R, Alriksson-Schmidt AI, Faye-Petersen O, Carlo W, Goldenberg R, Hauth JC: Early preterm birth: association between in utero exposure to acute inflammation and severe neurodevelopmental disability at 6 years of age. Am J Obstet Gynecol 2008, 198:466.e1-466.e11
60. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901 (Pubitemid 29375048)
61. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM: Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases. Nature 2000, 405:354-360 (Pubitemid 30337069)
62. Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999, 274:19919-19924 (Pubitemid 129519445)
63. Hudson BI, Carter AM, Harja E, Kalea AZ, Arriero M, Yang H, Grant PJ, Schmidt AM: Identification, classification, and expression of RAGE gene splice variants. FASEB J 2008, 22:1572-1580 (Pubitemid 351656797)
64. Raucci A, Cugusi S, Antonelli A, Barabino SM, Monti L, Bierhaus A, Reiss K, Saftig P, Bianchi ME: A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008, 22:3716-3727
65. Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M, Geroldi D: Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol 2005, 25:1032-1037 (Pubitemid 40627851)
66. Devangelio E, Santilli F, Formoso G, Ferroni P, Bucciarelli L, Michetti N, Clissa C, Ciabattoni G, Consoli A, Davì G: Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic Biol Med 2007, 43:511-518 (Pubitemid 47058227)
67. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A: Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 2005, 7:R817-R824
68. Jones SA: Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005, 175:3463-3468 (Pubitemid 41292002)
69. Lockwood CJ, Yen CF, Basar M, Kayisli UA, Martel M, Buhimschi I, Buhimschi C, Huang SJ, Krikun G, Schatz F: Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells. Am J Pathol 2008, 172:1571-1579 (Pubitemid 351793350)
70. Gao X, Zhang H, Schmidt AM, Zhang C: AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 2008, 295:H491-H498
71. Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J: Neutrophil derived human S100A12 (ENRAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003, 52:847-853 (Pubitemid 36613492)
72. Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N: Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J Rheumatol 2008, 35:752-756 (Pubitemid 351747112)
73. Bejar RF, Vaucher YE, Benirschke K, Berry CC: Postnatal white matter necrosis in preterm infants. J Perinatol 1992, 12:3-8
74. Ment LR, Vohr BR: Preterm birth and the developing brain. Lancet Neurol 2008, 7:378-379
75. Vaccarino FM, Fagel DM, Ganat Y, Maragnoli ME, Ment LR, Ohkubo Y, Schwartz ML, Silbereis J, Smith KM: Astroglial cells in development, regeneration, and repair. Neuroscientist 2007, 13:173-185 (Pubitemid 46524319)
76. Li Q, Michaud M, Stewart W, Schwartz M, Madri JA: Modeling the neurovascular niche: murine strain differences mimic the range of responses to chronic hypoxia in the premature newborn. J Neurosci Res 2008, 86:1227-1242 (Pubitemid 351571898)
77. Michetti F, Gazzolo D: S100B testing in pregnancy. Clin Chim Acta 2003, 335:1-7
78. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I: S100B's double life: Intracellular regulator and extracellular signal. Biochim Biophys Acta 2008, PMID: 19110011
79. Allore RJ, Friend WC, O'Hanlon D, Neilson KM, Baumal R, Dunn RJ, Marks A: Cloning and expression of the human S100 beta gene. J Biol Chem 1990, 265:15537-15543 (Pubitemid 20310949)
80. Van Eldik LJ, Wainwright MS: The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 2003, 21:97-108
81. Crossgrove JS, Li GJ, Zheng W: The choroid plexus removes beta-amyloid from brain cerebrospinal fluid. Exp Biol Med (Maywood) 2005, 230:771-776
82. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195 (Pubitemid 34773774)
83. Ponath G, Schettler C, Kaestner F, Voigt B, Wentker D, Arolt V, Rothermundt M: Autocrine S100B effects on astrocytes are mediated via RAGE. J Neuroimmunol 2007, 184:214-222 (Pubitemid 46366005)
84. Stewart JA, Urban MI: The postnatal accumulation of S-100 protein in mouse central nervous system. Modulation of protein synthesis and degradation Dev Biol 1972, 29:372-384
85. Hachem S, Laurenson AS, Hugnot JP, Legraverend C: Expression of S100B during embryonic development of the mouse cerebellum. BMC Dev Biol 2007, 7:17-31 (Pubitemid 46482309)
86. Dulay AT, Buhimschi IA, Zhao G, Luo G, Abdel-Razeq S, Cackovic M, Rosenberg VA, Pettker CM, Thung SF, Bahtiyar MO, Bhandari V, Buhimschi CS: Nucleated red blood cells are a direct response to mediators of inflammation in newborns with early-onset neonatal sepsis. Am J Obstet Gynecol 2008, 198:426.e1-426.e9